Literature DB >> 32030008

Immediate Postpartum Intrauterine Device in HIV-Infected Women: Experience from a Tertiary Care Center in Côte d'Ivoire.

Edouard N'guessan1, Franck Gbeli1, Jean-Marc Dia1, Privat Guie1, Nguessan Kouame Roseline1.   

Abstract

BACKGROUND: Immediate postpartum intrauterine device (PPIUD) is a good solution for reducing low contraceptive coverage in developing countries. However, its use in HIV-infected women is poorly documented. The objective of this study was to assess whether the risk of PPIUD complications was higher in HIV-infected women.
METHODS: A retrospective cohort study compared 64 HIV-infected women to 128 HIV-negative women who had had a PPIUD at the University Hospital of Treichville between January 2016 and March 2017, with a match at the insertion time of the PPIUD. The complications considered were pelvic pain, metrorrhagia and genital infections. Chi-squared test and relative risk were used to investigate the association between HIV infection and PPIUD complications.
RESULTS: HIV-infected patients had an average age of 33.1 years, and 85.9% of them were on antiretroviral therapy. PPIUD was inserted during cesarean section in 66.1% of cases. There was no significant association between HIV infection and PPIUD complications (RR = 0.7, 95% CI [0.4-1.3], p = 0.3). The risk of genital infections was not increased in HIV-infected women (RR = 0.6 [0.1-2.7], p = 0.7).
CONCLUSION: HIV infection does not increase the risk of PPIUD complications. This effective contraceptive strategy can be offered to HIV-infected women. It is therefore necessary to strengthen the training of maternity staff in the installation of PPIUD. © Federation of Obstetric & Gynecological Societies of India 2019.

Entities:  

Keywords:  AIDS infection; Complications; Copper IUD; HIV; PPIUD

Year:  2019        PMID: 32030008      PMCID: PMC6982613          DOI: 10.1007/s13224-019-01268-6

Source DB:  PubMed          Journal:  J Obstet Gynaecol India        ISSN: 0975-6434


  14 in total

1.  A facility birth can be the time to start family planning: postpartum intrauterine device experiences from six countries.

Authors:  Anne Pfitzer; Devon Mackenzie; Holly Blanchard; Yolande Hyjazi; Somesh Kumar; Serawit Lisanework Kassa; Bernabe Marinduque; Marie Grace Mateo; Beata Mukarugwiro; Fidele Ngabo; Shabana Zaeem; Zonobia Zafar; Jeffrey Michael Smith
Journal:  Int J Gynaecol Obstet       Date:  2015-06       Impact factor: 3.561

2.  Integrating family planning and prevention of mother to child HIV transmission in Zimbabwe.

Authors:  Clea C Sarnquist; Precious Moyo; Lynda Stranix-Chibanda; Tsungai Chipato; Jennifer L Kang; Yvonne A Maldonado
Journal:  Contraception       Date:  2013-11-12       Impact factor: 3.375

3.  Contraceptive failure of etonogestrel implant in patients treated with antiretrovirals including efavirenz.

Authors:  Nadia Leticee; Jean-Paul Viard; Amina Yamgnane; Marina Karmochkine; Alexandra Benachi
Journal:  Contraception       Date:  2011-10-27       Impact factor: 3.375

4.  [Intrauterine contraception: CNGOF Contraception Guidelines].

Authors:  F Vidal; L Paret; T Linet; Y Tanguy le Gac; P Guerby
Journal:  Gynecol Obstet Fertil Senol       Date:  2018-11-11

Review 5.  Safety of intrauterine devices among women with HIV: a systematic review.

Authors:  Naomi K Tepper; Kathryn M Curtis; Kavita Nanda; Denise J Jamieson
Journal:  Contraception       Date:  2016-06-22       Impact factor: 3.375

6.  Medical eligibility, contraceptive choice, and intrauterine device acceptance among HIV-infected women receiving antiretroviral therapy in Lilongwe, Malawi.

Authors:  Lisa B Haddad; Caryl Feldacker; Denise J Jamieson; Hannock Tweya; Carrie Cwiak; Amy G Bryant; Mina C Hosseinipour; Thomas Chaweza; Linly Mlundira; Fanny Kachale; Gretchen S Stuart; Irving Hoffman; Sam Phiri
Journal:  Int J Gynaecol Obstet       Date:  2014-05-13       Impact factor: 3.561

7.  A randomized trial of the intrauterine contraceptive device vs hormonal contraception in women who are infected with the human immunodeficiency virus.

Authors:  Elizabeth M Stringer; Christine Kaseba; Jens Levy; Moses Sinkala; Robert L Goldenberg; Benjamin H Chi; Inutu Matongo; Sten H Vermund; Mulindi Mwanahamuntu; Jeffrey S A Stringer
Journal:  Am J Obstet Gynecol       Date:  2007-08       Impact factor: 8.661

8.  Intrauterine Contraception Among Women Living With Human Immunodeficiency Virus: A Randomized Controlled Trial.

Authors:  Othman Kakaire; Josaphat Kayogoza Byamugisha; Nazarius Mbona Tumwesigye; Kristina Gemzell-Danielsson
Journal:  Obstet Gynecol       Date:  2015-11       Impact factor: 7.661

Review 9.  Contraception for the HIV-positive woman: a review of interactions between hormonal contraception and antiretroviral therapy.

Authors:  Jennifer A Robinson; Roxanne Jamshidi; Anne E Burke
Journal:  Infect Dis Obstet Gynecol       Date:  2012-08-14

10.  Modern contraceptive use, unmet need, and demand satisfied among women of reproductive age who are married or in a union in the focus countries of the Family Planning 2020 initiative: a systematic analysis using the Family Planning Estimation Tool.

Authors:  Niamh Cahill; Emily Sonneveldt; John Stover; Michelle Weinberger; Jessica Williamson; Chuchu Wei; Win Brown; Leontine Alkema
Journal:  Lancet       Date:  2017-12-05       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.